Analgesic activity of venlafaxine and its interactions with tramadol, celecoxib and amlodipine in mice

Indian Journal of Pharmacology

Volumn 38, Issue 3, 2006, Pages 181-184

  Jha, P ^a   Mazumdar, B ^a   Bhatt, J ^b  

^a PDU Medical College   (India)

^b Baroda Medical College   (India)

Author keywords

Antidepressant; Tail flick latency; Writhing

Indexed keywords

AMLODIPINE; ANTIDEPRESSANT AGENT; CELECOXIB; TRAMADOL; VENLAFAXINE;

ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG POTENTIATION; EVIDENCE BASED MEDICINE; FEMALE; LATENT PERIOD; MALE; MOUSE; NONHUMAN; PAIN THRESHOLD; PERIPHERAL NERVOUS SYSTEM; TAIL FLICK TEST; TASK PERFORMANCE; WRITHING TEST;

EID: 33745132183     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: 10.4103/0253-7613.25804     Document Type: Article

References (17)

1. Rafieian-Kopaei M, Sewell RDE. Newer antidepressants: analgesic and relative monoamine reuptake inhibitory potency. J Pharm Pharmacol 1994;46:1088.
2. th ed. Philadelphia: WB Saunders Co.; 1996.
3. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE. Opioid and non-opioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J Pharmacol Exp Ther 1992;260:275-85.
4. Lin LL, Lin AY, Knopf JL. Cytosolic phospholipase A2 is coupled to hormonally regulated release of arachidonic acid. Proc Natl Acad Sci USA 1992;89:6147-151.
5. D'Armour FE, Smith DL. A method for determining loss of pain sensation. J Pharmacol Exp Ther 1941;72:74-9.
6. Ramabadran K, Bansinath M. A critical analysis of the experimental evaluation of nociceptive reactions in animals. Pharmaceutical Res 1986;3:263-70.
7. Jung AC, Staiger T, Sullivan M. The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain. J Gen Intern Med 1997;12:384-9.
8. Singh VP, Jain NK, Kulkarni SK. On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor. Brain Res 2001;915:218-26.
9. Kiayias JA, Vlachou ED, Lakka-Papadodima E. Venlafaxine HCl in the treatment of painful peripheral diabetic neuropathy. Diabetes Care 2000;23:699.
10. Pernia A, Mico JA, Calderon E, Torres LM. Venlafaxine for the treatment of neuropathic pain. J Pain Symptom Manage 2000;19:408-1.
11. th ed. Edinburgh: Churchill Livingstone; 1999.
12. Hopwood SE, Owesson CA, Callado LF, McLaughlin DP, Stamford JA. Effects of chronic tramadol on pre- and post-synaptic measures of monoamine functions. J Psychopharmacol 2001;15:147-53.
13. Driessen B, Reimann W, Giertz H, Grunenthal G. Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro. Br J Pharmacol 1993;108:806-11.
14. Burnett FE, Scott LV, Weaver MG, Medbak SH, Dinan TG. The effect of naloxone on adrenocorticotropin and cortisol release and evidence for a reduced response in depression. J Affect Disord 1999;53:263-8.
15. Markowitz JS, Patrick KS. Venlafaxine-tramadol similarities. Med Hypotheses 1998;51:167-8.
16. Dray A, Urban L. New pharmacological strategies for pain relief. Annu Rev Pharmacol Toxicol 1996;36:262.
17. 2+ channels at the primary afferent neurons in mice. Eur J Pharmacol 2001;419:175-81.